SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001048462-10-000016
Filing Date
2010-04-15
Accepted
2010-04-15 16:26:39
Documents
1
Group Members
CHARLES E. DAVIDSONJOSEPH M. JACOBSTHETA INVESTORS LLCWEXFORD GP LLCWEXFORD SPECTRUM INVESTORS LLC

Document Format Files

Seq Description Document Type Size
1 WEXFORD CAPITAL SC13GA3 04-15-2010 formsc13ga3.htm SC 13G/A 236739
  Complete submission text file 0001048462-10-000016.txt   239052
Mailing Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617-349-4500
JAVELIN PHARMACEUTICALS, INC (Subject) CIK: 0000050710 (see all company filings)

IRS No.: 880471759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-62367 | Film No.: 10752297
SIC: 2834 Pharmaceutical Preparations

Mailing Address 411 W PUTNAM AVENUE GREENWICH CT 06830
Business Address 411 W PUTNAM AVENUE GREENWICH CT 06830 2038627000
WEXFORD CAPITAL LP (Filed by) CIK: 0001048462 (see all company filings)

IRS No.: 061442624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A